Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma (Q80206172)
Jump to navigation
Jump to search
scientific article published on 01 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma |
scientific article published on 01 April 2007 |
Statements
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma (English)
Franck Morschhauser
Michael Burgess
Lisette Sloots